Philippe Soubrié

12.9k total citations · 2 hit papers
126 papers, 10.8k citations indexed

About

Philippe Soubrié is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Philippe Soubrié has authored 126 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Cellular and Molecular Neuroscience, 68 papers in Molecular Biology and 34 papers in Pharmacology. Recurrent topics in Philippe Soubrié's work include Receptor Mechanisms and Signaling (63 papers), Neuropeptides and Animal Physiology (57 papers) and Neurotransmitter Receptor Influence on Behavior (37 papers). Philippe Soubrié is often cited by papers focused on Receptor Mechanisms and Signaling (63 papers), Neuropeptides and Animal Physiology (57 papers) and Neurotransmitter Receptor Influence on Behavior (37 papers). Philippe Soubrié collaborates with scholars based in France, Italy and United States. Philippe Soubrié's co-authors include Gérard Le Fur, G. Le Fur, M. Arnone, Jeanne Maruani, R. Steinberg, Martine Poncelet, Michel Héaulme, Francis Barth, Murielle Rinaldi‐Carmona and Guy Griebel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Hepatology.

In The Last Decade

Philippe Soubrié

125 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1994 1.5k citations Murielle Rinaldi‐Carmona, Francis Barth et al. profile →
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

1997 502 citations Jeanne Maruani, Martine Poncelet et al. profile →

Peers

Countries citing papers authored by Philippe Soubrié

Since Specialization

Citations

This map shows the geographic impact of Philippe Soubrié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Soubrié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Soubrié more than expected).

Fields of papers citing papers by Philippe Soubrié

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Soubrié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Soubrié. The network helps show where Philippe Soubrié may publish in the future.

Co-authorship network of co-authors of Philippe Soubrié

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Soubrié. A scholar is included among the top collaborators of Philippe Soubrié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Soubrié. Philippe Soubrié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716) 2004 ·Neuropsychopharmacology ·Caroline Cohen, Ghislaine Perrault, Guy Griebel, Philippe Soubrié	203
2	SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats 2004 ·Neuropharmacology ·Denis Boulay, Ronan Depoortère, Caroline Louis, Ghislaine Perrault, Guy Griebel, Philippe Soubrié	46
3	SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile 2003 ·Neuropsychopharmacology ·Y. Claustre, (unknown), Philippe Brun, Christiane Gueudet, (unknown), Richard Alonso, (unknown), André Oblin, (unknown), Dominique Françon, Marie‐Françoise Suaud‐Chagny, R. Steinberg, Mireille Sevrin, Hans E. Schoemaker, Pascal George, Philippe Soubrié, B. Scatton	41
4	Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders 2002 ·Proceedings of the National Academy of Sciences ·Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal, Jean Wagnon, Marc Pascal, B. Scatton, Jean‐Pierre Maffrand, Philippe Soubrié	381
5	SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}-4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin 1 Receptor: II. Neurochemical and Behavioral Characterization 2002 ·Journal of Pharmacology and Experimental Therapeutics ·R. Steinberg, Richard Alonso, L. Rouquier, Christophe Desvignes, (unknown), Annie Cudennec, M. Jung, Jacques Simiand, Guy Griebel, Xavier Emonds‐Alt, Gérard Le Fur, Philippe Soubrié	30
6	Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand, Guy Griebel, C Lacour, Gilles Guillon, Claude Barberis, (unknown), Philippe Soubrié, Dino Nisato, Marc Pascal, Rebecca M. Pruss, B. Scatton, Jean‐Pierre Maffrand, Gérard Le Fur	180
7	Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia 2002 ·Brain Research ·Anne Rémaury, Natalio Vita, (unknown), M. Jung, (unknown), Martine Poncelet, Jean‐Michel Culouscou, Gérard Le Fur, Philippe Soubrié, Daniel Caput, David Shire, Manfred Köpf, Pascual Ferrara	113
8	Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK₃ receptor antagonist 2002 ·Canadian Journal of Physiology and Pharmacology ·Xavier Emonds‐Alt, Vincenzo Proietto, R. Steinberg, Charles Advenier, (unknown), Emmanuel Naline, Christiane Gueudet, (unknown), Florence Oury-Donat, Martine Poncelet, P. Vilain, Gérard Le Fur, Jean‐Pierre Maffrand, Philippe Soubrié, Marc Pascal	26
9	Endogenous neurotensin down‐regulates dopamine efflux in the nucleus accumbens as revealed by SR‐142948A, a selective neurotensin receptor antagonist 2001 ·Journal of Neurochemistry ·P Brun, (unknown), Florence Sotty, R. Steinberg, Philippe Soubrié, Bernard Renaud, Marie‐Françoise Suaud‐Chagny	11
10	The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse 1998 ·British Journal of Pharmacology ·François H.T. Duong, Jacqueline Fournier, P.E. Keane, Jean‐Louis Guénet, Philippe Soubrié, Jean‐Marie Warter, Jacques Borg, Philippe Poindron	25
11	Central mediation of the cannabinoid cue 1996 ·Behavioural Pharmacology ·A. Pério, M Rinaldi-Carmona, Jeanne Maruani, Francis Barth, G. Le Fur, Philippe Soubrié	58
12	Evidence for a tachykinin/cholinergic mediation of D1, agonist-induced turning in mice 1996 ·Neuroscience Letters ·Martine Poncelet, J. Souilhac, Gérard Le Fur, Philippe Soubrié	6
13	Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin receptor stimulation 1996 ·Neuroscience ·M. Jung, (unknown), R. Steinberg, (unknown), Abdallah Hayar, (unknown), J. Souilhac, Xavier Emonds‐Alt, Philippe Soubrié, G. Le Fur	37
14	Neuropharmacological profile of non‐peptide neurotensin antagonists 1995 ·Fundamental and Clinical Pharmacology ·D. Gully, (unknown), Martine Poncelet, R. Steinberg, Philippe Soubrié, G. Le Fur, JP Maffrand	23
15	The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat 1995 ·Neuroreport ·Christiane Gueudet, Vincent Santucci, Murielle Rinaldi‐Carmona, Philippe Soubrié, Gérard Le Fur	41
16	Turning behavior induced in mice by a neurokinin A receptor agonist: Stereoselective blockade by SR 48968, a non-peptide receptor antagonist 1993 ·Neuroscience Letters ·Martine Poncelet, Christiane Gueudet, Xavier Emonds‐Alt, Jean-Claude Brelière, Gérard Le Fur, Philippe Soubrié	26
17	The σ receptor ligand SR 31742A increases neurotensin in the nucleus accumbens but not in the caudate-putamen of the rat 1993 ·European Journal of Pharmacology ·(unknown), P.E. Keane, Philippe Soubrié, Gérard Le Fur	5
18	Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical β-adrenoceptors 1992 ·European Journal of Pharmacology ·Jacques Simiand, P.E. Keane, (unknown), Xavier Langlois, (unknown), Patrick Martin, Angelo Bianchetti, Gérard Le Fur, Philippe Soubrié	41
19	Enhancement of neurite outgrowth from central nervous system neurons in primary culture by thrombin inhibitors 1991 ·Neuroscience Letters ·Claire Laurens, Jacqueline Fournier, Denis Delebassée, D. FREHEL, Thierry Gauthier, Philippe Soubrié	5
20	Rapid, sensitive, and simple method for quantification of both neurotoxic and neurotrophic effects of NMDA on cultured cerebellar granule cells 1990 ·Journal of Neuroscience Research ·Michel Didier, Michel Héaulme, Philippe Soubrié, Joël Bockaert, Jean‐Philippe Pin	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact